Discontinuation of Flovent in Dec 2023: Guidance from DOH
Discontinuation of Flovent in Dec 2023: Guidance from DOH Regarding the discontinuation of Flovent HFA and Diskus expected at the end of 2023, NYSDOH is proactively reviewing the status of medications within NYRx to ensure patients have a seamless transition to available products. The Corticosteroids-Inhaled drug class was reviewed at the September 2023 Drug Utilization

